Doseloop Beta

Oxcarbazepine

medication Under review

An anticonvulsant medication used primarily to control partial seizures in the treatment of epilepsy.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence for oxcarbazepine centers on its efficacy and safety as monotherapy for partial seizures, with clinical trials demonstrating superior seizure reduction at higher doses compared to lower doses in patients with uncontrolled epilepsy. However, studies strictly in healthy human subjects are scarce, with only preliminary psychomotor assessments available, showing minimal impact on memory and slight stimulant effects on certain functions. Overall consensus supports its role in epilepsy management but lacks robust data for benefits in healthy individuals, emphasizing the need for caution regarding adverse effects like fatigue and hyponatremia.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

RCT

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

ClinicalTrials.gov • 2005

Novartis Pharmaceuticals

RCT

Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures

Neurology • 2001 • n=96

Not specified

Preliminary

Memory and psychomotor effects of oxcarbazepine in healthy volunteers

Semantics Scholar • 1990

Not specified

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 1
Side effects noted 3